Upsher-Smith Laboratories LLC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$1.0Mgeneral payments (2019-2025)
$7,413research payments (2019-2025)
8,298clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $188K
2020 $229K
2021 $242K
2022 $231K
2023 $93K
2024 $19K
2025 $13K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Neurology (Psychiatry & Neurology) $574K
Nurse Practitioner $61K
Family Medicine $58K
Family $52K
Physician Assistant $37K
Internal Medicine $36K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Marshall Freeman Greensboro, NC Neurology (Psychiatry & Neurology) $160,083.48
Peter Mcallister Fairfield, CT Neurology (Psychiatry & Neurology) $50,259.52
Christina Treppendahl Ridgeland, MS Nurse Practitioner $39,937.46
Jack Schim Carlsbad, CA Neurology (Psychiatry & Neurology) $26,397.73
Susan Hutchinson Laguna Hills, CA Adult Medicine $23,399.09
Merle Diamond Chicago, IL Internal Medicine $11,735.77
Frank Berenson Atlanta, GA Neurology (Psychiatry & Neurology) $9,287.81
Peter Gottschalk Fairfield, CT Neurology (Psychiatry & Neurology) $7,608.59
Alan Rapoport Los Angeles, CA Neurology (Psychiatry & Neurology) $5,444.14
Philippe Backeljauw Cincinnati, OH Pediatric Endocrinology $4,675.00

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.